诊断学理论与实践 ›› 2018, Vol. 17 ›› Issue (05): 606-610.doi: 10.16150/j.1671-2870.2018.05.024
梁媛媛, 王璇, 汤建平
收稿日期:2018-07-30
出版日期:2018-10-25
发布日期:2018-10-25
通讯作者:
汤建平 E-mail: tangjp6512@126.com
基金资助:
Received:2018-07-30
Online:2018-10-25
Published:2018-10-25
中图分类号:
梁媛媛, 王璇, 汤建平. 干燥综合征合并肺间质病变的临床诊断治疗进展[J]. 诊断学理论与实践, 2018, 17(05): 606-610.
| [1] Nannini C, Jebakumar AJ, Crowson CS, et al.Primary Sjögren's syndrome 1976-2005 and associated interstitial lung disease: a population-based study of incidence and mortality[J]. BMJ Open,2013,3(11):e003569. [2] Singh AG, Singh S, Matteson EL.Rate, risk factors and causes of mortality in patients with Sjögren's syndrome: a systematic review and meta-analysis of cohort studies[J]. Rheumatology (Oxford),2016,55(3):450-460. [3] Flament T, Bigot A, Chaigne B, et al.Pulmonary manifestations of Sjögren's syndrome[J]. Eur Respir Rev,2016, 25(140):110-123. [4] Reina D, Roig Vilaseca D, Torrente-Segarra V, et al.Sjögren's syndrome-associated interstitial lung disease: A multicenter study[J]. Reumatol Clin,2016,12(4):201-205. [5] Papageorgiou A, Voulgarelis M, Tzioufas AG.Clinical picture, outcome and predictive factors of lymphoma in Sjögren syndrome[J]. Autoimmun Rev,2015,14(7):641-649. [6] Roca F, Dominique S, Schmidt J, et al.Interstitial lung disease in primary Sjögren's syndrome[J]. Autoimmun Rev,2017,16(1):48-54. [7] Palm O, Garen T, Berge Enger T, et al.Clinical pulmonary involvement in primary Sjögren's syndrome: prevalence, quality of life and mortality--a retrospective study based on registry data[J]. Rheumatology (Oxford),2013,52(1):173-179. [8] 高辉, 何菁, 张学武, 等. 原发性干燥综合征肺脏受累及其危险因素分析[J]. 中华风湿病学杂志,2015,19(5):306-312. [9] Li X, Xu B, Ma Y, et al.Clinical and laboratory profiles of primary Sjögren's syndrome in a Chinese population: A retrospective analysis of 315 patients[J]. Int J Rheum Dis,2015,18(4):439-446. [10] Kreider M, Highland K.Pulmonary involvement in Sjögren syndrome[J]. Semin Respir Crit Care Med,2014,35(2):255-264. [11] Enomoto Y, Takemura T, Hagiwara E, et al.Features of usual interstitial pneumonia in patients with primary Sjögren's syndrome compared with idiopathic pulmonary fibrosis[J]. Respir Investig,2014,52(4):227-235. [12] 阙雪莹, 肖卫国. 干燥综合征肺部病变的研究进展[J]. 医学综述,2017,23(4):743-746. [13] 高辉, 何菁, 邹雅丹, 等. 非口眼干起病的原发性干燥综合征肺脏受累患者临床特征分析[J]. 中华风湿病学杂志,2017,21(4):231-236. [14] Manfredi A, Sebastiani M, Cerri S, et al.Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement[J]. Clin Rheumatol,2017,36(6):1261-1268. [15] Fischer A, Lee JS, Cottin V.Interstitial lung disease evaluation: detecting connective tissue disease[J]. Respiration,2015,90(3):177-184. [16] Stefanski AL, Tomiak C, Pleyer U, et al.The Diagnosis and Treatment of Sjögren's Syndrome[J]. Dtsch Arztebl Int,2017,114(20):354-361. [17] Seror R, Theander E, Brun JG, et al.Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes(ESSPRI)[J]. Ann Rheum Dis,2015,74(5):859-866. [18] 刘倩, 赵振军, 张晓. 血清KL-6检测在结缔组织病肺间质病变中的意义[J]. 中华风湿病学杂志,2016,20(6):396-399. [19] Chen F, Lu X, Shu X, et al.Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study[J]. Intern Med J,2015,45(6):641-647. [20] Sambataro D, Sambataro G, Dal Bosco Y, et al.Present and future of biologic drugs in primary Sjögren's syndrome[J]. Expert Opin Biol Ther. 2017,17(1):63-75. [21] Oguz EO, Kucuksahin O, Turgay M, et al.Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study[J]. Clin Rheumatol,2016,35(3):663-666. [22] Sada PR, Isenberg D, Ciurtin C.Biologic treatment in Sjögren's syndrome[J]. Rheumatology (Oxford),2015,54(2):219-230. [23] Lin Y, Yi Q, Cheng D.Rapid progressive interstitial lung disease as initial manifestation of primary Sjögren's syndrome: a case report[J]. Int J Clin Exp Med,2014,7(12):5904-5908. [24] Izumi S, Iikura M, Hirano S.Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis[J]. N Engl J Med,2012,367(9):870-871. [25] 刘佩玲, 赵金霞, 刘湘源. 干燥综合征治疗指南:生物制剂的使用疲劳及炎性肌肉骨骼疼痛的治疗[J]. 中华风湿病学杂志,2017,21(1):67-70. [26] Gottenberg JE, Cinquetti G, Larroche C, et al.Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry[J]. Ann Rheum Dis,2013,72(6):1026-1031. [27] Justet A, Ottaviani S, Dieudé P, et al.Tocilizumab for refractory organising pneumonia associated with Sjögren's disease[J]. BMJ Case Rep,2015,(4):277-284. [28] Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, et al.Treatment of primary Sjögren syndrome with rituximab: a randomized trial[J]. Ann Intern Med,2014,160(4):233-242. [29] Raghu G.Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years[J]. Eur Respir J,2017,50(4):460-478. [30] 杨厚宇, 梁宗安. 尼达尼布治疗特发性肺间质纤维化安全性Meta分析[J]. 医学综述,2017,23(17):3503-3510. [31] 阮光峰, 黄家树, 黄琬雪, 等. 间充质干细胞对干燥综合征模型小鼠治疗效应的研究[J]. 同济大学学报(医学版),2016,37(1):7-11. [32] 路臻豪, 汤建平. 间充质干细胞在干燥综合征发病机制中的作用与治疗前景[J]. 中华风湿病学杂志,2013, 17(7):492-494. [33] 龚邦东, 路臻豪, 景波, 等. 间充质干细胞对干燥综合征患者活化CD4+T细胞miRNA表达谱的影响[J]. 中华风湿病学杂志,2015,19(7):435-439. [34] 房星星, 路臻豪, 汤建平, 等. MSCs通过促分泌TGF-β1、IL-6和IL-10抑制干燥综合征患者CD4+T细胞的活化增殖[J]. 同济大学学报(医学版),2016,37(4):31-35. [35] Xu J, Wang D, Liu D, et al.Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome[J]. Blood,2012,120(15):3142-3151. [36] Kohno N, Akiyama M, Kyoizumi S, et al.Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma[J]. Jpn J Clin Oncol,1988, 18(3):203-216. [37] 马芹, 徐建华, 王芬, 等. 结缔组织病间质性肺病血清涎液化糖链抗原-6肺泡表面活性蛋白A和D及白细胞介素-6的变化及意义[J]. 中华风湿病学杂志,2017, 21(1):46-49. |
| [1] | 汤建平, 龚邦东. 干燥综合征的诊治现状、挑战和思考[J]. 诊断学理论与实践, 2022, 21(03): 291-298. |
| [2] | 陆弘逾, 顾俊, 王静, 曹亚峰, 宋陆茜, 范俊, 陈梅. 干燥综合征继发隐球菌性脑膜脑炎一例报告及相关自身免疫病文献复习[J]. 诊断学理论与实践, 2021, 20(05): 456-461. |
| [3] | 赵茜, 赵肖庆, 刁立诚, 孙菲, 郑捷, 朱雪梅, 曹华. 伴皮肤紫癜的原发性干燥综合征患者的临床特征分析[J]. 诊断学理论与实践, 2021, 20(02): 155-160. |
| [4] | 张诗敏, 吴海曦, 杜联军, 胡赟赟, 曹华. 影像学技术在皮肌炎内脏受累诊断及预后评估中的应用进展[J]. 诊断学理论与实践, 2021, 20(01): 98-103. |
| [5] | 王艳青, 黄琬雪, 梁媛媛, 吴珍珍, 王璇, 汤建平. 原发性干燥综合征患者合并周围神经病变的临床及实验室特点分析[J]. 诊断学理论与实践, 2019, 18(1): 51-55. |
| [6] | 龚邦东, 汤建平. 干燥综合征分类标准的时代演化及对临床诊断的指导价值[J]. 诊断学理论与实践, 2018, 17(03): 244-248. |
| [7] | 刘维超, 王苏丽, 陈盛, 林艳伟, 吕良敬,. 干燥综合征合并神经系统损害、抗利尿激素分泌异常综合征一例报告[J]. 诊断学理论与实践, 2016, 15(03): 331-332. |
| [8] | 周琳, 曹华, 郑捷,. 43例皮肌炎和临床无肌病型皮肌炎合并肺间质病变的临床分析[J]. 诊断学理论与实践, 2014, 13(03): 251-254. |
| [9] | 顾寒英, 施若非, 陈迎春, 王刚,. 干燥综合征合并中枢神经系统脱髓鞘疾病的临床特点分析[J]. 诊断学理论与实践, 2014, 13(01): 86-89. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
